Thanks for emailing that article!
L. Jay Katz, MD discusses Glaucoma 360 New Horizons Forum, an annual meeting presented by Glaucoma Research Foundation designed to speed the development of new therapies and diagnostics for glaucoma patients.
What is unique about Glaucoma 360 New Horizons Forum?
L. Jay Katz, MD: The unique feature for me is the gathering of individuals involved in all aspects of cutting edge technology in glaucoma care. It’s bringing together the clinicians, researchers, industry executives, regulatory agencies. It’s to me, the only place where you can have ready access to all these people in one room, which is fantastic.
What do you hope to gain from participating in Glaucoma 360?
Even though I feel like I’m trying to keep abreast of all the new developments in glaucoma, I’ve already heard things this morning that I did not know about so that, for my own education, is wonderful. In addition to that, I can go over and talk to various people that I don’t get the chance to talk to as much as I’d like to, talk about different ideas, talk about directions that I may go or they may go or we may collaborate. I see my peers here and ask them what the updates are in some of the other projects that they’re involved with so it’s a very quick way to gather information on all different levels, whether it’s keeping abreast of new developments in research, where things are in regulatory, the business side, and kind of compare notes.
I’d like to thank the Glaucoma Research Foundation for putting together Glaucoma 360. Specifically I’d like to thank Tom Brunner, Adrienne Graves, and Andrew Iwach for putting together really an outstanding program — I’m delighted to be here. In fact, one of my junior partners from Wills Eye Institute, Scott Fudemberg, made a point of coming here after he saw the program — unsolicited from me — because he thought it was an outstanding list of characters that are going to be speaking here and the topics that are going to be presented, so, congratulations.
L. Jay Katz, MD is director of the Glaucoma Service at the Wills Eye Institute and professor of Ophthalmology at Thomas Jefferson University in Philadelphia.
Last reviewed on February 05, 2019